# Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences reported Q4 and full-year [----] financial results, providing expectations for [----]. The company's stock experienced a dip due to missed EPS estimates and a failed study, despite strong INGREZZA sales.

### About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.  
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Neurocrine Biosciences, Inc. (NBIX) trading volume is up 97.12% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) social dominance is up 530.77% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) creators is up 70.42% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) engagements is up 3122.52% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) mentions is up 121.71% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) posts created is up 552.94% from the previous week.

### Price: $124.10
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/close.tsv)  
The stock price saw a minor dip of -1.92% in the last [--] hours, attributed to missed EPS estimates and the failure of the KINECT-DCP study, even with strong INGREZZA sales and positive analyst sentiment.  

24-Hour: 0.73%
7-Day: -11.57%
30-Day: -6.25%

1-Year High: $155.60 on 2025-12-10  
1-Year Low: $87.50 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/alt_rank.tsv)  
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #978 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +97  
[--] Month: [-----] +279  
[--] Months: [-----] +757  
[--] Year: [-----] +322  
1-Year High: [-----] on 2026-02-01  
1-Year Low: [--] on 2025-07-12  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +1  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-07-02  
1-Year Low: [--] on 2025-09-24  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [-------] +3,123%  
[--] Month: [-------] +102%  
[--] Months: [---------] -56%  
[--] Year: [---------] -2%  
1-Year High: [-------] on 2025-05-05  
1-Year Low: [---] on 2026-02-01  

Engagements by network (24h):
TikTok: [--]
News: [---]
Reddit: [--]
X: [-----]
YouTube: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +122%  
[--] Month: [---] +24%  
[--] Months: [-----] -86%  
[--] Year: [------] +261%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
TikTok: [--]
News: [--]
Reddit: [--]
X: [---]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is down 19% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +70%  
[--] Month: [---] -1.60%  
[--] Months: [---] -93%  
[--] Year: [------] +701%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [--] on 2025-12-07  

The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@OracleEarnings](/creator/twitter/OracleEarnings)   | [--]    | [------]    | [--]     | [---]         |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [-----]     | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@AIStockSavvy](/creator/twitter/AIStockSavvy)       | [--]    | [------]    | [--]     | [--]          |
| [@Earnings_Oracle](/creator/twitter/Earnings_Oracle) | [--]    | [---]       | [--]    | [--]          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@TradersCom](/creator/twitter/TradersCom)           | [--]    | [------]    | [--]     | [--]          |
| [@moneyforfun_](/creator/twitter/moneyforfun_)       | [--]    | [---]       | [--]     | [--]          |
| [@OpenOutcrier](/creator/twitter/OpenOutcrier)       | [--]   | [------]    | [--]     | [--]           |

[View More](/list/creators/neurocrine-biosciences-inc/100)
  
  
### Sentiment: 73%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/sentiment.tsv)  
Current Value: 73%  
Daily Average: 67%  
[--] Week: 50% no change  
[--] Month: 65% -11%  
[--] Months: 65% -26%  
[--] Year: 65% +21%  
1-Year High: 100% on 2025-07-20  
1-Year Low: 25% on 2025-09-15  

Most Supportive Themes:
- Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
- Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline.
- Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
  
Most Critical Themes:
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
  
  
  
### Social Dominance: 0.00739%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/social_dominance.tsv)  
Current Value: 0.00739%  
Daily Average: 0.021%  
[--] Week: 0.0082% +0.0069%  
[--] Month: 0.013% +0.0064%  
[--] Months: 0.013% -0.0073%  
[--] Year: 0.013% -0.019%  
1-Year High: 0.211% on 2025-07-03  
1-Year Low: 0.0021% on 2025-12-07  
  
  
### Market Dominance: 0.014%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_dominance.tsv)  
Current Value: 0.014%  
Daily Average: 0%  
1-Year High: 0.389% on 2025-04-09  
1-Year Low: 0.014% on 2026-02-14  
  
  
### Market Cap: $12,445,069,412
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_cap.tsv)  
Current Value: $12,445,069,412  
Daily Average: $13,008,289,386  
[--] Week: $12,445,069,412 -11%  
[--] Month: $12,457,113,028 -6.30%  
[--] Months: $12,457,113,028 -5.70%  
[--] Year: $12,457,113,028 +8.60%  
1-Year High: $15,517,197,780 on 2025-12-10  
1-Year Low: $8,990,517,324 on 2025-04-12  

### Top Neurocrine Biosciences, Inc. News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"Neurocrine Biosciences Reports Fourth-Quarter and Full-Year [----] Financial Results and Provides Financial Expectations for [----] /PRNewswire/ -- Neurocrine Biosciences Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter ended December [--] 2025"  
[News Link](https://www.prnewswire.com/news-releases/neurocrine-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-financial-expectations-for-2026-302685532.html) [@PRNewswire](/creator/x/PRNewswire) 2026-02-11T21:05Z 120.9K followers, [----] engagements



### Top Neurocrine Biosciences, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Earnings roundup: Neurocrine slumps Alnylam battles skeptics and Ascendis eyes a competitor $NBIX $ALNY $ASND by @realJacobBell https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/ https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/"  
[X Link](https://x.com/BioPharmaDive/status/2022360018042130840) [@BioPharmaDive](/creator/x/BioPharmaDive) 2026-02-13T17:19Z 13.7K followers, [---] engagements


"MDS wishes to acknowledge the following Gold Level supporters of the [----] #PASCongress: AskBio Medtronic Neurocrine Biosciences Inc. and Teva Pharmaceuticals. @ask_bio @Medtronic @neurocrine @tevapharm"  
[X Link](https://x.com/movedisorder/status/2022011570885472393) [@movedisorder](/creator/x/movedisorder) 2026-02-12T18:15Z 17.2K followers, [---] engagements


"$APP 🔴-18% ❌ $CSCO 🔴-10% ❌ $NBIX 🔴-10% 🎯✅ $HUBS 🟢+5% ❌ $NBIS 🟢+2.4% 🎯✅ $CROX 🟢+20% 🎯✅ $HWM 🟢+11% 🎯✅ $WST 🔴-5% 🎯✅ Total forecasts: [---] 📊 Correct: [---] 🎯✅ Missed: [---] ❌ Cumulative Return: +840M% 📈 Every prediction is posted before earnings and fully documented in the Highlights section. $ANET $ROKU $VRTX $ABNB $AMAT $TWLO $EXPE coming next @OracleEarnings After Close : $APP 🟢 $CSCO 🟢 $HUBS 🔴 $NBIX 🔴 Before open : $NBIS 🟢 $CROX 🟢 $HWM 🟢 $WST 🔴 We had this call before the print. Premium members were on it while the market was live. Total forecasts: [---] 📊 Correct: [---] 🎯✅"  
[X Link](https://x.com/OracleEarnings/status/2021984322413084969) [@OracleEarnings](/creator/x/OracleEarnings) 2026-02-12T16:26Z 13.8K followers, 20.5K engagements


"$NBIX #Crenessity growth is impressive. Bodes well for a potential launch of Atumelnant from $CRNX for the treatment of CAH in the long-term. $NBIX Reports Fourth-Quarter and Full-Year [----] Financial Results and Provides Financial Expectations for [----] https://t.co/wg8tgQQ7WW $NBIX Reports Fourth-Quarter and Full-Year [----] Financial Results and Provides Financial Expectations for [----] https://t.co/wg8tgQQ7WW"  
[X Link](https://x.com/doepke_michel/status/2021700835407769804) [@doepke_michel](/creator/x/doepke_michel) 2026-02-11T21:40Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing